Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
At retirement, target date funds typically rebalance toward conservative assets, adjusting to support withdrawals while aiming to preserve principal.
20,347 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Leaders from the G7 unveiled a plan to shrink reliance on China for rare earths, targeting caps by 2030 and rapid mil...
A single moment on a televised stage can set off a flood of opinions online. This article explains how trump sparks s...
ULTY’s weekly payouts look generous on the surface, yet a deeper dive shows a growing dependence on returning princip...
The 250th anniversary of The Wealth of Nations shines a spotlight on a potential shift away from pure free-market thi...
Oil rose past $100 per barrel as tensions involving Iran added a geopolitical layer to markets. Yet the S&P 500 showe...
Eagle Point Credit Corp. slashed its monthly distribution in April 2026 after a sharp NAV decline, spotlighting the r...
Could a single Vanguard ETF outpace the S&P 500 in 2026? This article breaks down why broad market exposure, discipli...
A couple earning about $150k aims to gift experiences to each other without secret money. A transparent, dedicated ‘s...
Space-focused stocks promise big gains but come with big swings. This guide breaks down how to evaluate could buying ...
The White House granted a brief window for buyers to acquire oil already en route from Russia, sparking a mixed marke...
An insider at Mirion Technologies reduced his stake by roughly $165,000 in a May 2026 move. This article explains how...